Work

Improving venous thromboembolism prophylaxis in hospitalized pediatric patients with inflammatory bowel disease

Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Objectives: Youth hospitalized with inflammatory bowel disease (IBD) are at risk for venous thromboembolism (VTE). Pharmacologic VTE prophylaxis with enoxaparin is routine in adults hospitalized with IBD, but standardized pediatric protocols are rare. Using quality improvement methods, we aimed to increase the rate of pharmacologic VTE prophylaxis amongst select hospitalized patients with IBD by reaching 90% algorithm adherence by June 2023 and sustaining. Methods: Current evidence, external institutional algorithms, and multidisciplinary collaboration (hematology, pharmacy, surgery) were used to create an algorithm for providing pharmacologic VTE prophylaxis with enoxaparin. The algorithm was implemented in February 2023 for all patients admitted with active IBD to a large, tertiary care children's hospital. Rates of algorithm adherence and rates of enoxaparin receipt during the project period were compared to baseline rates. Patient and provider education, electronic data tracking, and regular data auditing and review with providers were used to improve algorithm adherence. Reasons for non-adherence to the algorithm and rates of VTE, bleeding complications, and medication side effects during hospitalization were tracked. Results: < 0.001). Following algorithm introduction, there were no VTEs or reported complications from enoxaparin during hospitalization. Conclusions: The introduction of a standardized algorithm was associated with significantly increased rates of pharmacologic VTE prophylaxis amongst children hospitalized with IBD with no recorded adverse in-hospital events.
Source: JPGN Reports
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $1,900
OpenAlex ID: W7234934260
FWCI:
Cites: 17
Cited by:
Related to: 10